The firm's cytogenetic media, immunohistochemistry products, and fish probes have been certified for marketing in Europe.
A genomics researcher from North Carolina State University outlined efforts to learn more about human cancers by studying dogs and other animals with spontaneous malignancies.
Some geneticists who use arrays hope the new guidelines, which ACMG updated this month, will prompt other labs to adopt the technology and compel insurance firms to reimburse for the tests.
According to CEO Kevin King, Affy's "efforts to prepare the company for renewed revenue growth and profitability … have started to pay off."
Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.
The New York Times reports on the shifting interpretations of what some genetic variants mean over time.
In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.
MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.